Diljit Kaur‐Knudsen

1.7k total citations
13 papers, 181 citations indexed

About

Diljit Kaur‐Knudsen is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Diljit Kaur‐Knudsen has authored 13 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Pharmacology. Recurrent topics in Diljit Kaur‐Knudsen's work include Glutathione Transferases and Polymorphisms (4 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Diljit Kaur‐Knudsen is often cited by papers focused on Glutathione Transferases and Polymorphisms (4 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Diljit Kaur‐Knudsen collaborates with scholars based in Denmark and United States. Diljit Kaur‐Knudsen's co-authors include Stig E. Bojesen, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Torkil Menné, Berit Christina Carlsen, Claus Zachariae, Claus Henrik Nielsen, Nikolai Loft, Lone Skov and Christian Enevold and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and European Respiratory Journal.

In The Last Decade

Diljit Kaur‐Knudsen

12 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diljit Kaur‐Knudsen Denmark 8 51 45 38 28 28 13 181
Rebecca Spence United Kingdom 9 45 0.9× 40 0.9× 164 4.3× 14 0.5× 18 0.6× 10 317
Kelly Weiss United States 9 68 1.3× 153 3.4× 53 1.4× 18 0.6× 10 0.4× 17 340
Ines Schwarz Austria 6 79 1.5× 39 0.9× 12 0.3× 19 0.7× 25 0.9× 7 417
Giulio Cariani Italy 8 32 0.6× 22 0.5× 58 1.5× 33 1.2× 22 0.8× 13 286
Sherry Ngo New Zealand 10 86 1.7× 63 1.4× 13 0.3× 16 0.6× 6 0.2× 16 215
Mario Klingler Germany 10 89 1.7× 55 1.2× 12 0.3× 7 0.3× 27 1.0× 14 321
Enas Samir Nabih Egypt 11 110 2.2× 53 1.2× 27 0.7× 16 0.6× 4 0.1× 27 316
Pedro J. Santiago-Borrero Puerto Rico 9 38 0.7× 14 0.3× 9 0.2× 18 0.6× 7 0.3× 16 207
Carolin Lackner Austria 9 74 1.5× 59 1.3× 8 0.2× 30 1.1× 5 0.2× 13 308
Katarzyna Suchta Poland 6 84 1.6× 34 0.8× 16 0.4× 16 0.6× 10 0.4× 13 584

Countries citing papers authored by Diljit Kaur‐Knudsen

Since Specialization
Citations

This map shows the geographic impact of Diljit Kaur‐Knudsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diljit Kaur‐Knudsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diljit Kaur‐Knudsen more than expected).

Fields of papers citing papers by Diljit Kaur‐Knudsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diljit Kaur‐Knudsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diljit Kaur‐Knudsen. The network helps show where Diljit Kaur‐Knudsen may publish in the future.

Co-authorship network of co-authors of Diljit Kaur‐Knudsen

This figure shows the co-authorship network connecting the top 25 collaborators of Diljit Kaur‐Knudsen. A scholar is included among the top collaborators of Diljit Kaur‐Knudsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diljit Kaur‐Knudsen. Diljit Kaur‐Knudsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Loft, Nikolai, et al.. (2024). HLA ‐C*06:02 in Danish patients with psoriasis and response to biological treatment. The Journal of Dermatology. 52(1). 142–145. 1 indexed citations
2.
Enevold, Christian, Peter Riis Hansen, Diljit Kaur‐Knudsen, et al.. (2023). Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis. International Journal of Molecular Sciences. 24(7). 6111–6111. 21 indexed citations
3.
Kaur‐Knudsen, Diljit, et al.. (2022). Can patient-reported outcome measures be used to predict consultation needs in patients with psoriasis?: A survey study. Journal of Patient-Reported Outcomes. 6(1). 81–81. 1 indexed citations
4.
Kaur‐Knudsen, Diljit, et al.. (2015). Risk factors and mortality among patients with severe muco-cutaneous drug reactions.. PubMed. 62(8). A5122–A5122. 7 indexed citations
5.
Kaur‐Knudsen, Diljit, Stig E. Bojesen, & Børge G. Nordestgaard. (2014). CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population. Pharmacogenetics and Genomics. 24(4). 220–229. 5 indexed citations
6.
Kaur‐Knudsen, Diljit, Claus Zachariae, & Simon Francis Thomsen. (2013). [Stevens-Johnson syndrome and toxic epidermal necrolysis].. PubMed. 175(50). 3096–9.
7.
Kaur‐Knudsen, Diljit, Børge G. Nordestgaard, & Stig E. Bojesen. (2012). CHRNA3genotype, nicotine dependence, lung function and disease in the general population. European Respiratory Journal. 40(6). 1538–1544. 38 indexed citations
8.
Kaur‐Knudsen, Diljit, Stig E. Bojesen, & Børge G. Nordestgaard. (2012). Cytochrome P450 1B1 and 2C9 Genotypes and Risk of Ischemic Vascular Disease, Cancer, and Chronic Obstructive Pulmonary Disease. Current Vascular Pharmacology. 10(4). 512–520. 9 indexed citations
9.
Kaur‐Knudsen, Diljit, Torkil Menné, & Berit Christina Carlsen. (2012). Systemic allergic dermatitis following airborne exposure to 1,2‐benzisothiazolin‐3‐one. Contact Dermatitis. 67(5). 310–312. 16 indexed citations
10.
Kaur‐Knudsen, Diljit, Stig E. Bojesen, Anne Tybjærg‐Hansen, & Børge G. Nordestgaard. (2011). Nicotinic Acetylcholine Receptor Polymorphism, Smoking Behavior, and Tobacco-Related Cancer and Lung and Cardiovascular Diseases: A Cohort Study. Journal of Clinical Oncology. 29(21). 2875–2882. 44 indexed citations
11.
Kaur‐Knudsen, Diljit, Børge G. Nordestgaard, & Stig E. Bojesen. (2010). CYP2C9 genotype does not affect risk of tobacco-related cancer in the general population. Cancer Epidemiology. 34(2). 178–183. 3 indexed citations
12.
Kaur‐Knudsen, Diljit, Stig E. Bojesen, & Børge G. Nordestgaard. (2009). Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52 000 individuals. The Pharmacogenomics Journal. 9(5). 327–332. 16 indexed citations
13.
Kaur‐Knudsen, Diljit, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, & Stig E. Bojesen. (2009). CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50 000 individuals. Pharmacogenetics and Genomics. 19(9). 685–694. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026